These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11499510)

  • 21. CMT-3 inhibits orthodontic tooth displacement in the rat.
    Bildt MM; Henneman S; Maltha JC; Kuijpers-Jagtman AM; Von den Hoff JW
    Arch Oral Biol; 2007 Jun; 52(6):571-8. PubMed ID: 17174265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells.
    Bildt MM; Snoek-Van Beurden AM; DeGroot J; Van El B; Kuijpers-Jagtman AM; Von den Hoff JW
    J Periodontal Res; 2006 Oct; 41(5):463-70. PubMed ID: 16953823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Significance of Matrix Metalloproteinases in Oral Diseases.
    Maciejczyk M; Pietrzykowska A; Zalewska A; Knaś M; Daniszewska I
    Adv Clin Exp Med; 2016; 25(2):383-90. PubMed ID: 27627574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.
    Gu Y; Lee HM; Simon SR; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):595-601. PubMed ID: 21651982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
    Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
    J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumor cell invasiveness by chemically modified tetracyclines.
    Gu Y; Lee HM; Roemer EJ; Musacchia L; Golub LM; Simon SR
    Curr Med Chem; 2001 Feb; 8(3):261-70. PubMed ID: 11172681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
    Castro MM; Kandasamy AD; Youssef N; Schulz R
    Pharmacol Res; 2011 Dec; 64(6):551-60. PubMed ID: 21689755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc-inhibited MMP-mediated collagen degradation after different dentine demineralization procedures.
    Toledano M; Yamauti M; Osorio E; Osorio R
    Caries Res; 2012; 46(3):201-7. PubMed ID: 22516944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity.
    Ryan ME; Usman A; Ramamurthy NS; Golub LM; Greenwald RA
    Curr Med Chem; 2001 Feb; 8(3):305-16. PubMed ID: 11172685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postradiation Matrix Metalloproteinase-20 Expression and Its Impact on Dental Micromorphology and Radiation-Related Caries.
    Gomes-Silva W; Prado-Ribeiro AC; Brandão TB; Morais-Faria K; de Castro Junior G; Mak MP; Lopes MA; Rocha MM; Salo T; Tjäderhane L; de Goes MF; Santos-Silva AR
    Caries Res; 2017; 51(3):216-224. PubMed ID: 28359051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
    Shiraga M; Yano S; Yamamoto A; Ogawa H; Goto H; Miki T; Miki K; Zhang H; Sone S
    Cancer Res; 2002 Oct; 62(20):5967-73. PubMed ID: 12384564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head and neck radiotherapy does not increase gelatinase (metalloproteinase-2 and -9) expression or activity in teeth irradiated in vivo.
    Gomes-Silva W; Prado Ribeiro AC; de Castro Junior G; Salvajoli JV; Rangel Palmier N; Lopes MA; Rocha MM; de Goes MF; Brandão TB; Santos-Silva AR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Aug; 124(2):175-182. PubMed ID: 28602264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers.
    Lokeshwar BL
    Pharmacol Res; 2011 Feb; 63(2):146-50. PubMed ID: 21093590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.
    Holmes SG; Still K; Buttle DJ; Bishop NJ; Grabowski PS
    Bone; 2004 Aug; 35(2):471-8. PubMed ID: 15268899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases.
    Acharya MR; Venitz J; Figg WD; Sparreboom A
    Drug Resist Updat; 2004 Jun; 7(3):195-208. PubMed ID: 15296861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model for clinical evaluation of the effect of antimicrobial agents on carious dentin.
    Garcia MB; Nör JE; Schneider LG; Bretz WA
    Am J Dent; 2001 Jun; 14(3):119-22. PubMed ID: 11572285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium fluoride inhibits MMP-2 and MMP-9.
    Kato MT; Bolanho A; Zarella BL; Salo T; Tjäderhane L; Buzalaf MA
    J Dent Res; 2014 Jan; 93(1):74-7. PubMed ID: 24196489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of matrix metalloproteinases in dental erosion.
    Buzalaf MA; Kato MT; Hannas AR
    Adv Dent Res; 2012 Sep; 24(2):72-6. PubMed ID: 22899684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs).
    Marcial BL; Sousa SF; Santos HF; Ramos MJ
    J Biomol Struct Dyn; 2014 Dec; 32(12):1907-18. PubMed ID: 24125013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
    Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
    J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.